Infection Patterns Matter in Selecting Arthritis Therapies
MANCHESTER, England — The risks for infection are broadly similar regardless of the biologic or targeted synthetic disease-modifying drug used to treat inflammatory arthritis, but different patterns of infection do exist across these advanced therapies, delegates were told at the recent British Society for Rheumatology (BSR) 2025 Annual Meeting.
'There are so many advanced therapies, and they're all very good from an efficacy or effectiveness side of things. So now treatment decisions are more about cost, infection, or comorbidity profiles,' Mark Russell, PhD, an academic clinical lecturer at the Centre for Rheumatic Disease, King's College London, England, told Medscape Medical News .
He said that some of the differences in infection safety profiles with advanced therapies included an 'increased risk for fungal infections with IL [interleukin]-17 inhibitors and shingles with JAK [Janus kinase] inhibitors,' compared with tumor necrosis factor (TNF) inhibitors.
However, 'whereas TB [tuberculosis] used to be an issue with TNF inhibitors, it's not really an issue after screening. It will probably be the same for JAK inhibitors when we start using the shingles vaccine more widely in the younger population,' Russell said.
Rising Use of Advanced Therapies
In addition to presenting a comprehensive overview of the infection risks associated with newer biologics and small molecules at the meeting, he presented data separately showing that there had been a 62% increase in the use of biologics or small-molecule targeted therapies for various indications over the past 5 years in England. He also showed that around half a million people in England, or 1% of the total population, were prescribed a biologic or targeted therapy in 2025 for any immune-mediated inflammatory disease, which included inflammatory bowel disease and inflammatory arthritis, among others.
Infection Risk Across Biologic Classes
Some of the different types of infection across biologic drug classes highlighted by Russell were an increased risk with IL-6 inhibitors for cellulitis, diverticulitis, diverticular perforation, and erysipelas (a type of skin infection involving the dermis layer), compared with TNF inhibitors.
Mark Russell, PhD
Also, rituximab has been associated with higher rates of lower respiratory tract and lung infections than TNF inhibitors, as well as greater incidences of sepsis, bacteremia, viremia, and fungal infections.
Higher rates of Candida infections have been reported for the IL-17 inhibitors secukinumab, ixekizumab, and, in particular, bimekizumab, which inhibits both IL-17A and IL-17F vs TNF inhibitors.
JAK inhibitors are known to raise the risk for herpes zoster by a substantially greater extent than TNF inhibitors. In the ORAL Surveillance trial of tofacitinib vs the TNF inhibitors adalimumab or etanercept for patients with rheumatoid arthritis, the rate of zoster infection was about 12% with either high- or low-dose tofacitinib compared with 4% for TNF inhibitors. Incidence of herpes zoster was 3.75 per 100 patient-years for tofacitinib 5 mg twice daily and 3.94 per 100 patient-years for tofacitinib 10 mg twice daily compared with 1.18 per 100 patient-years for TNF inhibitors.
The tyrosine kinase 2 (TYK2) inhibitor deucravacitinib, which is approved to treat plaque psoriasis and is in development for psoriatic arthritis and lupus, as well as other TYK2 inhibitors in development, has shown 'a pretty bland' infection profile, depending on whether COVID-19 data are included, Russell said. However, 'there does appear to be a risk for acne and folliculitis with TYK2 inhibitors, certainly in some smaller studies,' he said, although it is unclear why this is the case.
Explaining and Mitigating Risk
What is 'really important' is how infection risk is communicated to patients, Russell said. 'Remembering relative vs absolute risk. So, a drug has a 50% increased risk of infection, or it increases your risk by only one in 1000; it's really important how you frame that.'
Other factors that are 'much more influential' than use of advanced therapies should also be studied for predicting future infection risk, he said, such as age, prior infection (particularly if hospitalization occurred), steroid use, and lymphopenia.
Mitigation strategies include TB screening for everyone (irrespective of which advanced therapy was being considered), vaccination, and Pneumocystis jirovecii pneumonia prophylaxis for patients at risk, such as those who may be taking rituximab with steroids and have low immunoglobulin levels.
Russell had received research support from Sandoz UK. In addition, Russell reported receiving honoraria from AbbVie, Biogen, Lilly, Galapagos, Menarini, UCB, and Vifor Pharma, and support for attending educational meetings from Lilly, Pfizer, Janssen, and UCB.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
2 hours ago
- Forbes
Summer Solstice 2025: Date, Time And How It Works
The sun rises at Stonehenge, near Amesbury, in Wiltshire, southern England on June 21, 2023, during ... More the Summer Solstice festival, which dates back thousands of years, celebrating the longest day of the year. (Photo by DANIEL LEAL/AFP via Getty Images) The June solstice marks the longest day of the year in the Northern Hemisphere and the shortest in the Southern Hemisphere. But what exactly causes this astronomical event? Here's everything you need to know about the summer solstice and the winter solstice in June 2025, including the dates and where to livestream it from Stonehenge in the U.K. Called the summer solstice in the Northern Hemisphere because it heralds the beginning of the new astronomical season of summer, the event takes place this year at precisely 02:42 UTC on Saturday, June 21, 2025 (10:42 p.m. EDT on Friday, June 20). The solstice is one of four major waymarkers of Earth's journey around the sun, the others being the other solstice in December and the two equinoxes in September and March. All are a consequence of the 23.5-degree tilt of Earth's axis with respect to the plane of the solar system. That tilt causes different parts of the planet to get more or less hours of daylight according to the time of year. It's the tilt that causes Earth's seasons. During the summer solstice, the Northern Hemisphere tilts toward the sun, allowing it to appear at its highest point in the sky at noon. The opposite is the case in the Southern Hemisphere. On the date of the June solstice, the sun shines directly overhead at the Tropic of Cancer, an imaginary line around Earth at 23.5 degrees north of the equator (through Mexico, India and Egypt). At the North Pole, the sun doesn't set, while at the South Pole, it doesn't rise. Though the solstice itself isn't easily perceptible, it is often associated with visible changes in the sun's path. The exact point on the horizon that the sun appears to rise and set changes throughout the year. On the June solstice, the sun rises at its most extreme point on the northeast horizon, reaches its highest point in the sky at noon, and sets at its most extreme point on the northwest horizon. It's for that reason that the solstice is celebrated at Stonehenge in the U.K., a monument that is thought to align with the rising sun on the date of the June solstice. English Heritage offers a YouTube livestream of the sunrise on the solstice. Wishing you clear skies and wide eyes.
Yahoo
3 hours ago
- Yahoo
Women less likely to get care for potentially fatal heart condition
Women are less likely than men to be given treatment for a potentially fatal heart condition, according to a new analysis. Researchers in the UK found women are 11% less likely to be referred to a hospital specialist after a diagnosis of the heart valve disease aortic stenosis. Academics said the findings show 'inequities in management and care of this common and serious condition' after they also found differences in care among south Asian and black patients as well as those from poorer backgrounds. Aortic stenosis, a narrowing of the aortic valve or the area immediately around it, leads to obstruction of the blood flow from the heart, which leads to symptoms including dizziness, fatigue, chest pain and breathlessness. The condition is more common in elderly people. It is not possible to reverse but treatments can include a transcatheter aortic valve implantation (TAVI) or valve replacement surgery. If left untreated it can lead to serious complications, including heart failure, heart rhythm abnormalities, and death. The analysis suggests some people are less likely to receive this treatment. Experts from England's University of Leicester examined GP data on 155,000 people diagnosed with aortic stenosis between 2000 and 2022 in England. Presenting their findings to the British Cardiovascular Society conference in Manchester, experts said as well as women being less likely to be referred for hospital care, they are 39% less likely to have a procedure to replace their aortic valve. Researchers also found people living in poorer neighbourhoods are 7% less likely to be referred for hospital care after a diagnosis compared to people from wealthier neighbourhoods. Meanwhile, black patients are 48% less likely to undergo a procedure to replace their aortic valve compared to white patients. South Asian patients are 27% less likely to undergo a procedure compared to their white counterparts, according to the study, which was funded by the National Institute for Health and Care Research (NIHR) and supported by NIHR Leicester Biomedical Research Centre. Dr Anvesha Singh, associate professor at the University of Leicester and consultant cardiologist, who was involved in the research, said: 'Previous studies have shown lower rates of valve replacement in women, and clinicians had assumed that women were less likely to be diagnosed with aortic stenosis. 'This analysis using large, real-world data clearly shows that this is not the case, giving us the clearest picture yet of what is happening in day-to-day clinical practice. 'Our study highlights potential inequities in management and care of this common and serious condition. More research is needed to understand the reasons for this and the true prevalence of aortic stenosis in different groups.'
Yahoo
3 hours ago
- Yahoo
Rare orchid returns from brink of extinction
A project to bring back one of the UK's rarest wildflowers has shown its first signs of success, experts said. The lady's slipper orchid was thought to be extinct by the early 20th Century, until a single plant was discovered in a remote area of the Yorkshire Dales in 1930. Its location was kept secret, with volunteers providing round-the-clock monitoring over several decades to prevent the plant being dug up and stolen. A scheme was launched two years ago to plant hand-reared orchids, with a plant discovered last June the first to germinate "of its own accord" since 1930, according to the Yorkshire Wildlife Trust (YWT). "The lady's slipper is a real icon of limestone habitats," Jonathan Leadley, from YWT, explained. "Where we've got limestone geology there's often a wealth of wildlife, but we've lost so much of the wildlife from these habitats. "This is a real flagship, like a superstar." Efforts to boost the population began in the 1990s, with a plea for help that resulted in a small number of privately-owned, wild-sourced orchids being offered as part of a captive breeding programme. Plants were reintroduced to locations in the north of England - which were also kept secret to avoid the ongoing threat of theft - with the project led by YWT since 2023. Orchids were propagated in Kew Gardens' laboratory, with young plants then nurtured by a network of volunteer specialists managed by the National Trust. Mike Fay, Kew senior research leader, said it had been a "flagship" conservation scheme for many years. "The appearance of a seedling is incredibly exciting and offers us hope," he said. Kevin Walker, from the Botanical Society of Britain and Ireland, paid tribute to the "hundreds of volunteers and enthusiasts who have carefully nurtured [the plant] back into the wild". Mr Leadley said that while "only a minority of people" stole plants, it was "certainly" still a threat. "When all this effort is being put in by lots of people to try and bring a species back from the brink of extinction, we really don't want all of that effort to go to waste by a selfish individual pinching that plant," he said. "We've got to keep it guarded for now, but hopefully at some point in the future there'll be so many of these plants out there that everybody will be able to enjoy them." Listen to highlights from North Yorkshire on BBC Sounds, catch up with the latest episode of Look North. Species pushed to 'brink of collapse' - report How to save native woodlands from invasive shrubs - one tree at a time Judi Dench celebrates after community secures site Yorkshire Wildlife Trust
